PCYC

Pharmacyclics, Inc. News Headlines

$114.83
*  
2.62
2.33%
Get PCYC Alerts
*Delayed - data as of Oct. 20, 2014  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PCYC After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Sector Update: Health Stocks Higher Pre-Bell
10/20/2014 8:54:23 AM - MT Newswires


Sector Update: Health Care
10/20/2014 8:53:17 AM - MT Newswires


Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy - Analyst Blog
10/17/2014 6:15:00 PM - Zacks.com


Sector Update: Health Stocks Higher Pre-Bell
10/17/2014 9:21:20 AM - MT Newswires


Sector Update: Health Care
10/17/2014 9:19:42 AM - MT Newswires


IMBRUVICA Gets Marketing Approval From EC For Treatment Of Two Blood Cancers
10/17/2014 9:14:00 AM - RTT News


AFFX In Harmony, SRPT, IBIO Focusing On Ebola, PCYC Inks Deal With Roche
10/17/2014 12:53:00 AM - RTT News


Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg
10/15/2014 8:45:02 AM - Motley Fool


Bristol-Myers Collaborates for Opdivo-Imbruvica Combo - Analyst Blog
10/14/2014 5:20:00 PM - Zacks.com


Interesting PCYC Put And Call Options For January 2017
10/13/2014 11:56:47 AM - BNK Invest


Bristol-Myers, Pharmacyclics And Janssen Collaborate On OPDIVO And IMBRUVICA
10/13/2014 8:28:00 AM - RTT News


15 Surprising Cancer Statistics
10/12/2014 9:41:02 AM - Motley Fool


Stocks Under Pressure Amid Global Economic Concerns - U.S. Commentary
10/7/2014 10:25:00 AM - RTT News


Individual Investor Portfolio: Major Sectors Are Beginning To Move In Opposing Directions
10/4/2014 3:39:00 AM - Seeking Alpha


Gilead Sciences, Inc. Stock's Stunning New Opportunity
9/30/2014 9:15:02 AM - Motley Fool


FDA Decision On Imbruvica Will Push Pharmacyclics Higher
9/29/2014 1:32:00 PM - Seeking Alpha


Cramer's Lightning Round - People Need H&R Block More Than Ever (9/17/14)
9/18/2014 4:53:00 AM - Seeking Alpha


Modest Weakness Remains Visible On Wall Street - U.S. Commentary
9/11/2014 12:04:00 PM - RTT News


Stocks Remain Nearly Flat In Mid-Day Trading - U.S. Commentary
9/10/2014 12:16:00 PM - RTT News


Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership - Stocks in the News
9/3/2014 6:47:20 PM - Zacks.com


Gilead: Rising Short Interest Provides Yet Another Reason To Own The Stock
8/15/2014 2:40:00 PM - Seeking Alpha


Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
8/13/2014 3:06:00 AM - Zacks.com


Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
8/12/2014 2:06:00 PM - Investopedia


Patient Bulls Finally Get A New Entry Point, Thanks To Inflation Fears
8/4/2014 4:45:00 PM - Seeking Alpha


Pharmacyclics Incurs Q2 Loss, Revenues Up on Imbruvica Sales - Analyst Blog
8/1/2014 5:10:00 PM - Zacks.com